[{"address1": "1 Commonwealth Lane", "address2": "No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to conduct clinical trials for the GMP grade CTM-GDT. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 66, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 38143, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jieming  Zeng M.D., Ph.D.", "age": 50, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 102037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 38, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 35, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.9007, "open": 1.845, "dayLow": 1.84, "dayHigh": 1.87, "regularMarketPreviousClose": 1.9007, "regularMarketOpen": 1.845, "regularMarketDayLow": 1.84, "regularMarketDayHigh": 1.87, "payoutRatio": 0.0, "beta": -0.349, "forwardPE": -12.266666, "volume": 2546, "regularMarketVolume": 2546, "averageVolume": 115180, "averageVolume10days": 104660, "averageDailyVolume10Day": 104660, "bid": 1.93, "ask": 1.9, "bidSize": 1, "askSize": 1, "marketCap": 21590030, "fiftyTwoWeekLow": 1.65, "fiftyTwoWeekHigh": 4.05, "allTimeHigh": 9.25, "allTimeLow": 1.2, "priceToSalesTrailing12Months": 29.580448, "fiftyDayAverage": 2.09102, "twoHundredDayAverage": 2.20047, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18943928, "profitMargins": 0.0, "floatShares": 3679298, "sharesOutstanding": 11733712, "sharesShort": 22080, "sharesShortPriorMonth": 103710, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0019, "heldPercentInsiders": 0.67355, "heldPercentInstitutions": 0.0019699999, "shortRatio": 0.1, "shortPercentOfFloat": 0.0064, "impliedSharesOutstanding": 11733712, "bookValue": 0.619, "priceToBook": 2.9725363, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -3672060, "trailingEps": -0.25, "forwardEps": -0.15, "enterpriseToRevenue": 25.955, "enterpriseToEbitda": -5.957, "52WeekChange": -0.2157591, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 1.84, "recommendationKey": "none", "totalCash": 2854958, "totalCashPerShare": 0.247, "ebitda": -3180003, "totalDebt": 489604, "quickRatio": 4.305, "currentRatio": 5.807, "totalRevenue": 729875, "debtToEquity": 6.779, "revenuePerShare": 0.063, "returnOnAssets": -0.22851999, "returnOnEquity": -0.42330003, "grossProfits": 675254, "freeCashflow": -2369023, "operatingCashflow": -3153215, "revenueGrowth": 1.01, "grossMargins": 0.92516, "ebitdaMargins": 0.0, "operatingMargins": -4.52169, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1764354085, "regularMarketTime": 1764363600, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.1935573, "regularMarketPrice": 1.84, "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "postMarketChangePercent": -1.0869554, "postMarketPrice": 1.82, "postMarketChange": -0.01999998, "regularMarketChange": -0.06069994, "regularMarketDayRange": "1.84 - 1.87", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 115180, "fiftyTwoWeekLowChange": 0.19000006, "fiftyTwoWeekLowChangePercent": 0.115151554, "fiftyTwoWeekRange": "1.65 - 4.05", "fiftyTwoWeekHighChange": -2.21, "fiftyTwoWeekHighChangePercent": -0.545679, "fiftyTwoWeekChangePercent": -21.57591, "earningsTimestampStart": 1745870400, "earningsTimestampEnd": 1745870400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.25, "epsForward": -0.15, "fiftyDayAverageChange": -0.25102007, "fiftyDayAverageChangePercent": -0.120046705, "twoHundredDayAverageChange": -0.36046994, "twoHundredDayAverageChangePercent": -0.16381498, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "cryptoTradeable": false, "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]